Personal information

Human Genetics, Pharmacogenomics, Genomics, Precision Medicine
Spain

Biography

Degree in Biology and Master's Degree in Biomedicine from the University of Granada, and University Expert in Medical Genetics and Genomics from the Catholic University San Antonio of Murcia. Enrolled in the Doctoral Programme in Clinical Medicine and Public Health.

In 2014, she began her training in biomedicine as part of the Master in Regenerative Biomedicine, where she developed her master's thesis entitled: "Polymorphisms in toxicant metabolizing genes and their implication in prostate cancer". Thanks to her laboratory skills and dedication, in 2015 she was offered a training contract as a research fellow at the Genomics and Genotyping Unit of the Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO). Since then, she has acquired extensive experience in techniques such as next generation sequencing (preparation and enrichment of DNA and RNA libraries for NGS); genotyping, methylation and expression analysis using microarrays; quantitative and digital PCR; sample handling, organization and quality control; identification and treatment of problematic samples, optimization of protocols and interaction with users of the center; training and support in the use of specific techniques and in the use of new equipment, as well as advice on experimental design and management of training workshops.

Later, in 2016, she became part of the pharmacogenetics group at the GENyO Center and at the Pharmacy Department of the San Cecilio University Hospital, as a technical collaborator of the group with a contract related to the European project "U-PGx - Ubiquitous Pharmacogenomics" (funded by the Horizon 2020 research and innovation program). This project aimed to address the main challenges and barriers to the implementation of pharmacogenetic testing in patient care, taking into account the diversity of health systems and citizens across Europe, thus promoting an approach to precision medicine. During this period, she has participated in numerous projects related to pharmacogenetics, presented communications at national and international congresses and participated in the publication of relevant articles in the field.

Activities

Employment (3)

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO): Granada, Andalucía, ES

2022-01 to present | PhD student
Employment
Source: Self-asserted source
Antúnez-Rodríguez, A.

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO): Granada, Andalucía, ES

2016-11 to 2021-12 | Researcher in pharmacogenomics
Employment
Source: Self-asserted source
Antúnez-Rodríguez, A.

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO): Granada, Andalucía, ES

2015-10 to 2016-04 | Researcher (Non-Academic) (Genomics and Genotyping Unit)
Employment
Source: Self-asserted source
Antúnez-Rodríguez, A.

Education and qualifications (3)

Universidad Católica San Antonio de Murcia: Murcia, Murcia, ES

2021-02-14 | Experto Universitario en Genética Médica y Genómica
Qualification
Source: Self-asserted source
Antúnez-Rodríguez, A.

Universidad de Granada: Granada, Andalucía, ES

2014 to 2015 | Biomedicine master's degree
Education
Source: Self-asserted source
Antúnez-Rodríguez, A.

Universidad de Granada: Granada, Andalucía, ES

2008 to 2014 | Biology bachelor's degree
Education
Source: Self-asserted source
Antúnez-Rodríguez, A.

Funding (3)

Búsqueda de marcadores genéticos y epigenéticos en respuesta al tratamiento antiagregante en pacientes con SCA-stent para su aplicación mediante un algoritmo de prescripción

2021-09 to present | Grant
Ministerio de Ciencia e Innovación (Madrid, ES)
GRANT_NUMBER:

PID2020-113823RB-I00

Source: Self-asserted source
Antúnez-Rodríguez, A.

Algoritmo de decisión para prevención de eventos cardiovasculares basado en tecnología NGS para pacientes con síndrome coronario agudo sometidos a intervención coronaria percutánea. Estudios funcionales.

2020-06 to 2023-03 | Grant
Consejería de Conocimiento, Investigación y Universidad, Junta de Andalucía (Sevilla, ES)
GRANT_NUMBER:

PY20_01155

Source: Self-asserted source
Antúnez-Rodríguez, A.

Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen

2016-01-01 to 2021-12-31 | Grant
European Commission (Brussels, BE)
GRANT_NUMBER: 668353
Source: Self-asserted source
Antúnez-Rodríguez, A. via DimensionsWizard

Works (12)

Targeted next-generation sequencing panel to investigate antiplatelet adverse reactions in acute coronary syndrome patients undergoing percutaneous coronary intervention with stenting

Thrombosis Research
2024 | Journal article
EID:

2-s2.0-85195791064

Part of ISSN: 18792472 00493848
Contributors: Antúnez-Rodríguez, A.; García-Rodríguez, S.; Pozo-Agundo, A.; Sánchez-Ramos, J.G.; Moreno-Escobar, E.; Triviño-Juárez, J.M.; Martínez-González, L.J.; Dávila-Fajardo, C.L.
Source: Self-asserted source
Antúnez-Rodríguez, A. via Scopus - Elsevier

Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome

Biomedicine and Pharmacotherapy
2023 | Journal article
EID:

2-s2.0-85176466358

Part of ISSN: 19506007 07533322
Contributors: Castaño-Amores, C.; Antúnez-Rodríguez, A.; Pozo-Agundo, A.; García-Rodríguez, S.; Martínez-González, L.J.; Dávila-Fajardo, C.L.
Source: Self-asserted source
Antúnez-Rodríguez, A. via Scopus - Elsevier
grade
Preferred source (of 2)‎

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

The Lancet
2023-02 | Journal article
Part of ISSN: 0140-6736
Contributors: Jesse J Swen; Cathelijne H van der Wouden; Lisanne EN Manson; Heshu Abdullah-Koolmees; Kathrin Blagec; Tanja Blagus; Stefan Böhringer; Anne Cambon-Thomsen; Erika Cecchin; Ka-Chun Cheung et al.
Source: Self-asserted source
Antúnez-Rodríguez, A.
grade
Preferred source (of 2)‎

Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients

Pharmaceutics
2022 | Journal article
EID:

2-s2.0-85136960893

Part of ISSN: 19994923
Contributors: Blánquez-Martínez, D.; Díaz-Villamarín, X.; García-Rodríguez, S.; Antúnez-Rodríguez, A.; Pozo-Agundo, A.; Martínez-González, L.J.; Muñoz-ávila, J.I.; Dávila-Fajardo, C.L.
Source: Self-asserted source
Antúnez-Rodríguez, A. via Scopus - Elsevier
grade
Preferred source (of 3)‎

Pharmacogenetics of siponimod: A systematic review

Biomedicine & Pharmacotherapy
2022-08-12 | Journal article
Part of ISSN: 0753-3322
Contributors: Antúnez-Rodríguez, A.
Source: Self-asserted source
Antúnez-Rodríguez, A.
grade
Preferred source (of 2)‎

Circulating ptgs2, jag1, gucy2c and pgf mrna in peripheral blood and serum as potential biomarkers for patients with metastatic colon cancer

Journal of Clinical Medicine
2021 | Journal article
EID:

2-s2.0-85114071152

Part of ISSN: 20770383
Contributors: Jimenez-Luna, C.; González-Flores, E.; Ortiz, R.; Martínez-González, L.J.; Antúnez-Rodríguez, A.; Expósito-Ruiz, M.; Melguizo, C.; Caba, O.; Prados, J.
Source: Self-asserted source
Antúnez-Rodríguez, A. via Scopus - Elsevier
grade
Preferred source (of 3)‎

Genetic polymorphisms affecting ranibizumab response in high myopia patients

Pharmaceutics
2021 | Journal article
EID:

2-s2.0-85120329906

Part of ISSN: 19994923
Contributors: Blánquez-Martínez, D.; Díaz-Villamarín, X.; Antúnez-Rodríguez, A.; Pozo-Agundo, A.; Muñoz-ávila, J.I.; Martínez-González, L.J.; Dávila-Fajardo, C.L.
Source: Self-asserted source
Antúnez-Rodríguez, A. via Scopus - Elsevier
grade
Preferred source (of 3)‎

Identification of mirnas as viable aggressiveness biomarkers for prostate cancer

Biomedicines
2021 | Journal article
EID:

2-s2.0-85108180276

Part of ISSN: 22279059
Contributors: Martínez-González, L.J.; Sánchez-Conde, V.; González-Cabezuelo, J.M.; Antunez-Rodríguez, A.; Andrés-León, E.; Robles-Fernandez, I.; Lorente, J.A.; Vázquez-Alonso, F.; Alvarez-Cubero, M.J.
Source: Self-asserted source
Antúnez-Rodríguez, A. via Scopus - Elsevier
grade
Preferred source (of 3)‎

Pharmacogenetic polymorphisms affecting bisoprolol response

Biomedicine & Pharmacotherapy
2021-10 | Journal article
Part of ISSN: 0753-3322
Source: Self-asserted source
Antúnez-Rodríguez, A.
grade
Preferred source (of 2)‎

Genetic variants affecting anti-vegf drug response in polypoidal choroidal vasculopathy patients: A systematic review and meta-analysis

Genes
2020 | Journal article
EID:

2-s2.0-85096142495

Part of ISSN: 20734425
Contributors: Díaz-Villamarín, X.; Blánquez-Martínez, D.; Pozo-Agundo, A.; Pérez-Gutiérrez, A.M.; Muñoz-ávila, J.I.; Antúnez-Rodríguez, A.; Fernández-Gómez, A.E.; García-Navas, P.; Martínez-González, L.J.; Dávila-Fajardo, C.L.
Source: Self-asserted source
Antúnez-Rodríguez, A. via Scopus - Elsevier
grade
Preferred source (of 3)‎

Genetic variants in xenobiotic detoxification enzymes, antioxidant defenses and hormonal pathways as biomarkers of susceptibility to prostate cancer

Science of The Total Environment
2020-04-30 | Journal article
Part of ISSN: 0048-9697
Source: Self-asserted source
Antúnez-Rodríguez, A.
grade
Preferred source (of 2)‎

Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine

Genes
2019-04-01 | Journal article
Part of ISSN: 2073-4425
Source: Self-asserted source
Antúnez-Rodríguez, A.
grade
Preferred source (of 3)‎